Mukka Proteins to Acquire 51% Stake in Aqua Marine for up to ₹15 Crore
Mukka Proteins will acquire a 51% stake in Aqua Marine for up to ₹15 crore. The investment aims to expand core business and optimize operations. Aqua Marine, a manufacturer of fish meals and fish oil, had a turnover of ₹32.15 crore in FY25. The acquisition is expected to be completed by September 30, 2026.
The acquisition involves a significant investment and stake in another company, which can have a material impact on Mukka Proteins' business operations and market presence.
The acquisition is strategic and aims to expand the company's core business, which is viewed positively.
Mukka Proteins Limited announced today, 12th June 2026, that its Board of Directors has approved a strategic investment to acquire a 51% stake in Aqua Marine, a partnership firm.
The investment will be made through capital contribution in one or more tranches, not exceeding ₹15,00,00,000 (Rupees Fifteen Crores Only).
Aqua Marine is engaged in the manufacturing of fish meals and fish oil. For the financial year 2024-25, Aqua Marine reported a turnover of ₹32,15,07,660 and a Profit After Tax (PAT) of ₹1,067,656. The company was incorporated on 01-04-2022.
The acquisition is part of Mukka Proteins' strategic plan to expand its core business, focusing on capacity expansion and optimization of operational processes to enhance production efficiency and market reach. This transaction is not a related party transaction.
The indicative time period for the completion of the acquisition is 30th September 2026.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.